Valuation: NIOX Group Plc

Market Cap 290M 387M 346M 320M 542M 36.77B 551M 3.84B 1.52B 19.26B 1.45B 1.42B 60.73B P/E 2026 *
37x
P/E 2027 * 26x
Enterprise Value 262M 351M 313M 289M 490M 33.28B 498M 3.48B 1.38B 17.44B 1.32B 1.29B 54.97B EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.71x
Free-Float
82.11%
Yield 2026 *
2.68%
Yield 2027 * 3.03%
1 day+1.47%
1 week+1.18%
Current month-0.29%
1 month+1.78%
3 months+9.21%
6 months+6.50%
Current year+3.61%
1 week 66
Extreme 66
80
1 month 65
Extreme 65
80
Current year 53.84
Extreme 53.84
80
1 year 53.84
Extreme 53.84
80
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 16/01/2025
Director of Finance/CFO - 14/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 08/02/2018
Director/Board Member - 02/09/2019
Chairman 73 05/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/05/26 Buy

Chief Financial Officer

34,127 0.0081%
29/05/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/05/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+1.18%-1.71%+2.69% 387M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.45%+2.07%+33.05%+64.08% 400.47B
Weighted average by Cap. -0.26%+2.66%+40.99%+82.12%

Financials

2026 *2027 *
Net sales 50.36M 67.37M 60.16M 55.57M 94.22M 6.39B 95.78M 669M 265M 3.35B 253M 247M 10.56B 54.23M 72.54M 64.78M 59.84M 101M 6.89B 103M 720M 285M 3.61B 272M 266M 11.37B
Net income 8.5M 11.37M 10.15M 9.38M 15.9M 1.08B 16.17M 113M 44.69M 565M 42.67M 41.76M 1.78B 11.23M 15.03M 13.42M 12.4M 21.02M 1.43B 21.36M 149M 59.06M 747M 56.39M 55.19M 2.36B
Net Debt -27.45M -36.72M -32.79M -30.3M -51.36M -3.49B -52.21M -365M -144M -1.83B -138M -135M -5.76B -34.23M -45.78M -40.88M -37.77M -64.04M -4.35B -65.1M -455M -180M -2.28B -172M -168M -7.18B
Projected Income Statement - Annual - NIOX Group Plc
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
23/10/26 GBX 68.80 +1.47% 104,057
22/10/26 GBX 67.80 +2.73% 15,793,009
21/10/26 GBX 66.00 -4.35% 447,932
20/10/26 GBX 69.00 0.00% 346,503
19/10/26 GBX 69.00 +1.47% 399,721
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - NIOX Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.6880GBP
Average target price
0.8240GBP
Spread / Average Target
+19.77%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - NIOX Group Plc